Takeda Strikes Possible Deal, Halts Nev. Actos Cancer Trial
Takeda Pharmaceutical Co. Ltd. said Thursday it has reached a tentative settlement mid-trial with two Nevada plaintiffs alleging the company's diabetes drug Actos caused cancer, halting the jury trial after more...To view the full article, register now.
Already a subscriber? Click here to view full article